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Biology

Novel Histone Deacetylase Inhibitors to
Elucidate Repeat Associated Gene Silencing
Mechanisms in Drosophila
Emily Chi
Mentors: Sarah Elgin, Elena Gracheva and Flavio Ballante
Repetitious elements constitute a major portion of eukaryotic genomes. Silencing
mechanisms are required to recognize and prevent their expression in cells. Silencing of
repetitious elements can be achieved by formation of heterochromatin. To study this
mechanism we utilized a transgenic construct containing 256 copies of a 36 bp lac
Operon fragment placed upstream of an hsp70-white reporter, inserted into the
Drosophila melanogaster genome. In Drosophila, expression of the white gene results in
a red eye phenotype; sporadic silencing of this gene following juxtaposition with
heterochromatin results in a patchy red eye phenotype referred to as Position Effect
Variegation (PEV). Previous studies from the Elgin laboratory have shown that
insertion of the lacO-hsp70-white transgene at the base of chromosome arm 2L results
in strong silencing, sensitive to HP1 depletion, indicating heterochromatin packaging.
A genetic screen suggested that the lacO-hsp70-white PEV phenotype is sensitive to
mutations in genes coding for histone deacetylases (HDACs). These results led us to
test several small molecule HDAC inhibitors (HDACIs), including novel HDACIs
designed and synthetized by the Marshall laboratory (Biochemistry Dept, Washington
University). An initial test of 12 potent human HDACIs, with diverse selectivity profiles
for the ~10 HDACs present (Apicidin, Entinostat, Panobinostat, PCI-34051, SAHA,
Scriptaid, Largazole, SD-L-256, Trichostatin A, Tubastatin A, T247, and Compound 4),
performed on the Drosophila reporter line showed that the selected drugs did not cause
any detrimental effects on fly development, with the exception of SAHA at its maximum
concentration. We selected HDAC3 and HDAC6 inhibitors, compounds SD-L-256,
Largazole, 6q, and 4l (Marshall lab, unpublished) for a second, more precise drug screen
with optimized drug concentrations and fly population densities. Results from this
screen suggest that selective inhibition of HDAC3 or HDAC6 differentially affects
suppression of lacO-hsp70-white silencing. In the future, more detailed investigation is
needed to fully characterize the process.

28

Spring 2017 WUSHTA

